Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1986;64(3):365–374.

Approaches to prevention and early detection of cardiomyopathies: Memorandum from a WHO Meeting*

PMCID: PMC2490879  PMID: 3533298

Abstract

A meeting on cardiomyopathies was held in Geneva on 25-27 March 1985 to review the state of understanding concerning these diseases and to update the information and recommendations contained in the published report of the WHO Expert Committee on Cardiomyopathies which had met in 1983. Particular emphasis was given to discussing new scientific knowledge, priorities for etiological research, proposals for cooperation between research centres in developed and developing countries, early detection of cardiomyopathies, and possible population studies related to the disease.

Full text

PDF
365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelmann W. H. Classification and natural history of primary myocardial disease. Prog Cardiovasc Dis. 1984 Sep-Oct;27(2):73–94. doi: 10.1016/0033-0620(84)90020-3. [DOI] [PubMed] [Google Scholar]
  2. Amorim D. S., Olsen E. G. Assessment of heart neurons in dilated (congestive) cardiomyopathy. Br Heart J. 1982 Jan;47(1):11–18. doi: 10.1136/hrt.47.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baim D. S., McDowell A. V., Cherniles J., Monrad E. S., Parker J. A., Edelson J., Braunwald E., Grossman W. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. N Engl J Med. 1983 Sep 29;309(13):748–756. doi: 10.1056/NEJM198309293091302. [DOI] [PubMed] [Google Scholar]
  4. Bjarnason I., Hardarson T., Jonsson S. Cardiac arrhythmias in hypertrophic cardiomyopathy. Br Heart J. 1982 Sep;48(3):198–203. doi: 10.1136/hrt.48.3.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  6. ELSON S. H., ABELMANN W. H. EFFECTS OF MUSCULAR ACTIVITY UPON THE ACUTE MYOCARDITIS OF C3H MICE INFECTED WITH TRYPANOSOMA CRUZI. Am Heart J. 1965 May;69:629–636. doi: 10.1016/0002-8703(65)90245-0. [DOI] [PubMed] [Google Scholar]
  7. Edwards W. D. Myocarditis and endomyocardial biopsy. Cardiol Clin. 1984 Nov;2(4):647–656. [PubMed] [Google Scholar]
  8. Factor S. M., Minase T., Cho S., Dominitz R., Sonnenblick E. H. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation. 1982 Aug;66(2):342–354. doi: 10.1161/01.cir.66.2.342. [DOI] [PubMed] [Google Scholar]
  9. Fowles R. E., Mason J. W. Endomyocardial biopsy. Ann Intern Med. 1982 Dec;97(6):885–894. doi: 10.7326/0003-4819-97-6-885. [DOI] [PubMed] [Google Scholar]
  10. Franciosa J. A. Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure. Prog Cardiovasc Dis. 1982 Jan-Feb;24(4):319–330. doi: 10.1016/0033-0620(82)90009-3. [DOI] [PubMed] [Google Scholar]
  11. Grossman W., McLaurin L. P., Rolett E. L. Alterations in left ventricular relaxation and diastolic compliance in congestive cardiomyopathy. Cardiovasc Res. 1979 Sep;13(9):514–522. doi: 10.1093/cvr/13.9.514. [DOI] [PubMed] [Google Scholar]
  12. Gu B. Q. Pathology of Keshan disease. A comprehensive review. Chin Med J (Engl) 1983 Apr;96(4):251–261. [PubMed] [Google Scholar]
  13. Hassell L. A., Fowles R. E., Stinson E. B. Patients with congestive cardiomyopathy as cardiac transplant recipients. Indications for and results of cardiac transplantation and comparison with patients with coronary artery disease. Am J Cardiol. 1981 Jun;47(6):1205–1209. doi: 10.1016/0002-9149(81)90248-4. [DOI] [PubMed] [Google Scholar]
  14. Kawai C., Matsumori A., Kumagai N., Tokuda M. Experimental Coxsackie virus B-3 and B-4 myocarditis in mice. Jpn Circ J. 1978 Jan;42(1):43–47. doi: 10.1253/jcj.42.43. [DOI] [PubMed] [Google Scholar]
  15. Kawai C., Wakabayashi A., Matsumura T., Yui Y. Reappearance of beriberi heart disease in Japan. A study of 23 cases. Am J Med. 1980 Sep;69(3):383–386. doi: 10.1016/0002-9343(80)90008-x. [DOI] [PubMed] [Google Scholar]
  16. Kereiakes D. J., Parmley W. W. Myocarditis and cardiomyopathy. Am Heart J. 1984 Nov;108(5):1318–1326. doi: 10.1016/0002-8703(84)90760-9. [DOI] [PubMed] [Google Scholar]
  17. Maron B. J., Savage D. D., Wolfson J. K., Epstein S. E. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol. 1981 Aug;48(2):252–257. doi: 10.1016/0002-9149(81)90604-4. [DOI] [PubMed] [Google Scholar]
  18. Mason J. W. Endomyocardial biopsy: the balance of success and failure. Circulation. 1985 Feb;71(2):185–188. doi: 10.1161/01.cir.71.2.185. [DOI] [PubMed] [Google Scholar]
  19. Matsumori A., Kawai C. An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation. 1982 Aug;66(2):355–360. doi: 10.1161/01.cir.66.2.355. [DOI] [PubMed] [Google Scholar]
  20. McKenna W. J., Krikler D. M., Goodwin J. F. Arrhythmias in dilated and hypertrophic cardiomyopathy. Med Clin North Am. 1984 Jul;68(4):983–1000. doi: 10.1016/s0025-7125(16)31110-5. [DOI] [PubMed] [Google Scholar]
  21. O'Connell J. B., Henkin R. E., Robinson J. A., Subramanian R., Scanlon P. J., Gunnar R. M. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation. 1984 Jul;70(1):58–62. doi: 10.1161/01.cir.70.1.58. [DOI] [PubMed] [Google Scholar]
  22. Pasternac A., Bourassa M. G. Pathogenesis of chest pain in patients with cardiomyopathies and normal coronary arteries. Int J Cardiol. 1983 Jun;3(3):273–280. doi: 10.1016/0167-5273(83)90168-7. [DOI] [PubMed] [Google Scholar]
  23. Raum W. J., Laks M. M., Garner D., Swerdloff R. S. Beta-adrenergic receptor and cyclic AMP alterations in the canine ventricular septum during long-term norepinephrine infusion: implications for hypertrophic cardiomyopathy. Circulation. 1983 Sep;68(3):693–699. doi: 10.1161/01.cir.68.3.693. [DOI] [PubMed] [Google Scholar]
  24. Saltissi S., Hockings B., Croft D. N., Webb-Peploe M. M. Thallium-201 myocardial imaging in patients with dilated and ischaemic cardiomyopathy. Br Heart J. 1981 Sep;46(3):290–295. doi: 10.1136/hrt.46.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Strain J. E., Grose R. M., Factor S. M., Fisher J. D. Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease. Circulation. 1983 Dec;68(6):1171–1181. doi: 10.1161/01.cir.68.6.1171. [DOI] [PubMed] [Google Scholar]
  26. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet. 1979 Jun 30;1(8131):1374–1376. doi: 10.1016/s0140-6736(79)92010-5. [DOI] [PubMed] [Google Scholar]
  27. Unverferth D. V., Mehegan J. P., Magorien R. D., Unverferth B. J., Leier C. V. Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy. Am J Cardiol. 1983 May 1;51(8):1392–1398. doi: 10.1016/0002-9149(83)90318-1. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES